Clinical application of nitric oxide synthase inhibitor for atopic dermatitis.
Morita
H
H
Semma
M
M
Hori
M
M
Kitano
Y
Y
D000293:Adolescent; D000328:Adult; D000594:Amino Acid Oxidoreductases / Q000037:antagonists & inhibitors*; D001120:Arginine / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000627:therapeutic use; D002148:Calmodulin-Binding Proteins / Q000037:antagonists & inhibitors*; D016022:Case-Control Studies; D002648:Child; D003876:Dermatitis, Atopic / Q000188:drug therapy*; D005260:Female; D006801:Humans; D008297:Male; D009252:NADPH Dehydrogenase / Q000037:antagonists & inhibitors*; D019001:Nitric Oxide Synthase; D019335:Nitroarginine; D009824:Ointments
D002148:Calmodulin-Binding Proteins; D009824:Ointments; D019335:Nitroarginine; D001120:Arginine; D019001:Nitric Oxide Synthase; D000594:Amino Acid Oxidoreductases; D009252:NADPH Dehydrogenase